☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
ustekinumab
PharmaShots Interview: Janssen's Andrew Greenspan Shares Insight About the New AGA Guidelines Recommending Stelara (Ustekinumab) a...
August 17, 2021
Bio-Thera Reports First Patient Dosing in P-III Study for BAT2206 Proposed Biosimilar of Stelara (ustekinumab)
July 16, 2021
Janssen Reports Five-Year Data of Stelara (ustekinumab) in P-lll LTE Study for Severe Crohn's Disease
October 12, 2020
Bio-Thera Initiates P-I Study of BAT2206 Proposed Biosimilar to Stelara (ustekinumab)
September 4, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.